Skip to main content

Table 1 Baseline characteristics of participants randomized to the Godelieve Denys-Struyf (GDS) treatment arm and treatment as usual (control) arm

From: Effect of Godelieve Denys-Struyf (GDS) muscle and articulation chain treatment on clinical variables of patients with chronic low back pain and lumbar disc degeneration: a pilot feasibility randomized controlled trial

 

GDS (n = 15)

Treatment as usual (n = 15)

Age, years, mean (SD)

59.0 (9.5)

57.5 (10.2)

Women, n (%)

7 (47)

8 (53)

Educational level, n (%)

 Primary or high school (12 years)

8 (53)

9 (60)

 College or university (< 4 years)

4 (27)

3 (20)

 University (≥ 4 years)

3(20)

3 (20)

 Smoking, n yes (%)

2 (13)

2 (13)

Marital status, n (%)

 Married

13 (87)

10 (67)

 Cohabitant

1 (7)

0

 Single

1 (7)

5 (33)

Employment status, n

 Employed

6 (40)

5 (33)

 Sick leave

4 (27)

4 (27)

 Disability pension

4 (27)

3 (20)

 Unemployed

0

2 (13)

 Age pensioned

5 (33)

3 (20)

Pain localization, n (%)

 Back pain

5 (33)

9 (60)

 Radiating pain to the buttocks and/or thighs

9 (60)

4 (27)

 Sensibility changes in back/buttocks/thighs

1 (7)

2 (13)

Diagnosis, n (%)

 Spinal stenosis without spondylolisthesis

9 (60)

8 (54)

 Spinal stenosis with spondylolisthesis

3 (20)

2 (13)

 Other degenerative disc disease

3 (20)

5 (33)

 Former disc surgerya

3 (20%)

3 (20%)

Pain duration, n (%)

 3–12 months

3 (20)

8 (54)

 12–24 months

6 (40)

1 (7)

 > 2 years

6 (40)

6 (40)

 Use pain medication weekly or more, n (%)

7 (47)

9 (60)

 Use sleep/relaxation medication weekly or more, n (%)

2 (13)

2 (13)

STaRt Back risk groups, n (%)

 Low

5 (33)

6 (40)

 Moderate

8 (53)

6 (40)

 High

2 (13)

3 (20)

  1. aNot spinal fusion surgery (exclusion criteria)